Lupus Research Alliance Awards Lupus Insight Prize To Two Trailblazers In CAR T Cell Therapy
The Lupus Research Alliance (LRA) awarded the 2024 Lupus Insight Prize to Drs. Marko Radic and Georg Schett for their pioneering work in CAR T cell therapy aimed at transforming lupus treatment. Honored at the FOCIS 2024 meeting, their research explores reprogramming T cells to target and eliminate cells contributing to lupus, potentially offering a revolutionary approach to managing the disease. Dr. Radic's research, supported by LRA funding, demonstrated significant efficacy in mouse models by targeting CD19, resulting in reduced disease symptoms and prolonged effects post-treatment. Dr. Schett advanced this research into clinical trials, reporting promising outcomes in patients with refractory lupus, including reduced disease activity and the ability to discontinue immunosuppressive drugs.
The Lupus Insight Prize recognizes researchers who have made impactful discoveries in lupus within the last five years, reflecting the LRA's commitment to advancing understanding and treatment options for this complex autoimmune disease. Their work represents a crucial step towards developing transformative therapies that could improve outcomes for lupus patients worldwide.
For more information about the Lupus Research Alliance and its initiatives, visit LupusResearch.org.

Comments
Post a Comment